Comparison of clinical efficacy, subjective user experience, and safety for two different core biopsy needles, the Achieve® and Marquee®
Autor: | Avani A. Pendse, Lisa M. Ho, James Ronald, Rendon C. Nelson, Hemant Desai, Rui Dai, Cole Ziegler, Benjamin Wildman-Tobriner |
---|---|
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
Portal triad Urology medicine.medical_treatment Biopsy 030218 nuclear medicine & medical imaging 03 medical and health sciences 0302 clinical medicine Internal medicine medicine Humans Radiology Nuclear Medicine and imaging Clinical efficacy Embolization Core (anatomy) Radiological and Ultrasound Technology medicine.diagnostic_test business.industry Medical record Gastroenterology Hepatology medicine.anatomical_structure Treatment Outcome Liver Needles 030220 oncology & carcinogenesis Liver biopsy Biopsy Large-Core Needle Complication Nuclear medicine business |
Zdroj: | Abdominal radiology (New York). 47(8) |
ISSN: | 2366-0058 |
Popis: | To compare clinical efficacy, subjective radiologist preference, and complication rates for two different core biopsy needles, the Achieve® and Marquee®. Retrospective review included consecutive patients who underwent 18 gauge non-targeted core liver biopsy, 30 with Achieve® (Merit Medical) and 30 with Marquee® (BD Bard) Pathologist (blinded to needle type) reviewed specimen total length, maximum width, and portal triad count. Sixteen radiologists subjectively rated (1 to 5(best)) each needle for cocking, firing, recoil, chamber exposure, handling, and overall. A medical records search of all (targeted and non-targeted) core liver biopsies 1/1/17–9/30/2020 compared rates of major (requiring transfusion and/or embolization) and minor (self-limited bleeding) hemorrhagic complications. Comparison between needle types was performed using t-test. For Achieve® and Marquee® needles, the respective mean (SD) for total length(mm) was 29.7(7.0) and 31.9(4.6), p = 0.1; max width(mm) was 0.78(0.1) and 0.85(0.1), p |
Databáze: | OpenAIRE |
Externí odkaz: |